252 related articles for article (PubMed ID: 29972745)
1. Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
Saloner B; Stoller KB; Alexander GC
N Engl J Med; 2018 Jul; 379(1):4-6. PubMed ID: 29972745
[No Abstract] [Full Text] [Related]
2. Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities.
Wakeman SE; Barnett ML
N Engl J Med; 2018 Jul; 379(1):1-4. PubMed ID: 29972748
[No Abstract] [Full Text] [Related]
3. Clinical treatment of opioid addiction and dependence.
Ling W; Rawson RA; Compton M
Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
[No Abstract] [Full Text] [Related]
4. Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.
Resnick RB
Ann Intern Med; 2003 Feb; 138(4):360. PubMed ID: 12585846
[No Abstract] [Full Text] [Related]
5. Treatment options for opiate addiction.
J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
[No Abstract] [Full Text] [Related]
6. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
Shastry S; Manini AF; Richardson LD; Lin MP
J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352
[No Abstract] [Full Text] [Related]
7. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
McCann DJ
Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
Bagley SM; Larochelle MR; Xuan Z; Wang N; Patel A; Bernson D; Silverstein M; Hadland SE; Land T; Samet JH; Walley AY
Ann Emerg Med; 2020 Jan; 75(1):29-38. PubMed ID: 31591014
[TBL] [Abstract][Full Text] [Related]
9. Addiction treatment in Russia.
Krupitsky E; Woody GE; Zvartau E; O'Brien CP
Lancet; 2010 Oct; 376(9747):1145. PubMed ID: 20888988
[No Abstract] [Full Text] [Related]
10. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
[TBL] [Abstract][Full Text] [Related]
11. Opioid Use Disorder and Pregnancy.
O'Donnell FT; Jackson DL
Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
[TBL] [Abstract][Full Text] [Related]
12. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
[TBL] [Abstract][Full Text] [Related]
13. Improving opioid dependency treatment.
Swoboda JT
J Am Board Fam Pract; 2003; 16(2):185-6. PubMed ID: 12665191
[No Abstract] [Full Text] [Related]
14. Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
Parrino MW; Maremmani AG; Samuels PN; Maremmani I
J Addict Dis; 2015; 34(2-3):255-62. PubMed ID: 26110357
[TBL] [Abstract][Full Text] [Related]
15. Community treatment programs take up buprenorphine.
Casadonte PP; Kolodner GF; Horton T; McMurphy SM
Sci Pract Perspect; 2004 Aug; 2(2):24-9. PubMed ID: 18552729
[TBL] [Abstract][Full Text] [Related]
16. Medication-Based Treatment to Address Opioid Use Disorder.
Leshner AI; Dzau VJ
JAMA; 2019 Jun; 321(21):2071-2072. PubMed ID: 31046072
[No Abstract] [Full Text] [Related]
17. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
Connery HS
Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
[TBL] [Abstract][Full Text] [Related]
18. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
Sigmon SC; Bigelow GE
Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
[No Abstract] [Full Text] [Related]
19. Evolving use of buprenorphine in the treatment of addiction.
Martin J
J Psychoactive Drugs; 2004 May; Suppl 2():129-37. PubMed ID: 15279125
[TBL] [Abstract][Full Text] [Related]
20. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
Kelty E; Hulse G
Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
